LA Private

December 3, 2024

BlackRock to acquire HPS Investment Partners for US$12bn

BlackRock, the world’s largest asset manager, has agreed to acquire HPS Investment Partners for US$12bn in an all-stock deal, accelerating its expansion into private credit markets. The acquisition, announced Tuesday, highlights CEO Larry Fink’s strategy to diversify the firm’s offerings beyond traditional equities and bonds. HPS, a New York-based private credit manager overseeing US$148bn in

BlackRock to acquire HPS Investment Partners for US$12bn Read More »

Hazer gets $6.2m to scale clean hydrogen tech

Hazer Group (ASX:HZR) has been awarded $6.2m in conditional funding from the Western Australian Government’s “Lower Carbon Grants Program – Gorgon Fund”. The program was established in 2024, and is backed by the Gorgon Joint Venture, a consortium including Chevron, ExxonMobil and Shell. Hazer Group specialises in the production of clean hydrogen and high-quality graphite. The

Hazer gets $6.2m to scale clean hydrogen tech Read More »

Empty shelves and $50m loss: Woolworths’ industrial woes

Woolworths Group (ASX:WOW) has reported significant disruptions to its supply chain as industrial action at four distribution centres—three in Victoria and one in New South Wales—continues into a 12th day. The strikes, initiated by the United Workers Union (UWU), stem from unresolved enterprise agreement negotiations, with the UWU demanding pay increases exceeding 25% over three

Empty shelves and $50m loss: Woolworths’ industrial woes Read More »

94% accuracy: INOVIQ’s game-changing ovarian cancer test

INOVIQ (ASX:IIQ) has announced a breakthrough in detecting ovarian cancer. The results are a step forward toward earlier detection of the disease, and early intervention is known to dramatically improve survival rates. There are no current recommended screening methods for asymptomatic women. The global market for ovarian cancer diagnostics was valued at $1.7bn in 2023,

94% accuracy: INOVIQ’s game-changing ovarian cancer test Read More »

94% accuracy: INOVIQ’s game-changing ovarian cancer test

INOVIQ (ASX:IIQ) has announced a breakthrough in detecting ovarian cancer. The results are a step forward toward earlier detection of the disease, and early intervention is known to dramatically improve survival rates. There are no current recommended screening methods for asymptomatic women. The global market for ovarian cancer diagnostics was valued at $1.7bn in 2023,

94% accuracy: INOVIQ’s game-changing ovarian cancer test Read More »